4//SEC Filing
Burroughs Amy L. 4
Accession 0001562180-25-000851
CIK 0001831363other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:25 PM ET
Size
7.6 KB
Accession
0001562180-25-000851
Insider Transaction Report
Form 4
Burroughs Amy L.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-30+1,075,000→ 1,075,000 totalExercise: $4.64Exp: 2035-01-29→ Common Stock (1,075,000 underlying) - Purchase
Common Stock
2024-11-30$5.11/sh+510$2,606→ 19,609 total
Footnotes (2)
- [F1]Includes an additional 510 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2024 that was not previously reported on the reporting person's Form 4 filed on December 9, 2024 due to an administrative error.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001872564
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:25 PM ET
- Size
- 7.6 KB